Manuscripts
Showing 1530 manuscripts.
Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women
Citation
Alice Stek, Brookie M Best, Jiajia Wang, Edmund V Capparelli, Sandra K Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Tim R Cressey, Lynne M Mofenson, Elizabeth Smith, David Shapiro, Mark Mirochnick. Pharmacokinetics of Once Versus Twice Daily Darunavir in Pregnant HIV-Infected Women. Journal of Acquired Immune Deficiency Syndromes. 2015. 70: 33-41. PMID: 25950206
Year
Journal
Study
Frequent Nevirapine Resistance in Infants Infected by HIV-1 via Breastfeeding while on Nevirapine Prophylaxis: Results of the BAN Study
Citation
JA Nelson, A Fokar, MG Hudgens, KJ Compliment, JT Hawkins, G Tegha, DD Kamwendo, D Kayira, IA Mofolo, AP Kourtis, DJ Jamieson, CM Van Der Horst, SA Fiscus. Frequent Nevirapine Resistance in Infants Infected by HIV-1 via Breastfeeding while on Nevirapine Prophylaxis: Results of the BAN Study. AIDS. 2022. PMID: 26186128Journal
Immunologic and Virologic Outcomes of Treatment Switch Strategies After Combination Antiretroviral Treatment Failure Among Perinatally HIV-infected Children and Adolescents in the United States
Citation
Lee Fairlie, Brad Karalius, Kunjal Patel, Russell B. Van Dyke, Rohan Hazra, Miguel A. HernĂ¡n, George K Siberry, George R. Seage III, Allison Agwu, Hermann Mendez, Andrew Wiznia for PHACS and IMPAACT.. Immunologic and Virologic Outcomes of Treatment Switch Strategies After Combination Antiretroviral Treatment Failure Among Perinatally HIV-infected Children and Adolescents in the United States. AIDS. 2022. 29: 2109-19. PMID: 26182197Journal
Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women
Citation
Anna Tran, Brookie M. Best, Alice Stek, Jiajia Wang, Edmund V. Capparelli, Sandra K. Burchett, Regis Kreitchmann, Kittipong Rungruengthanakit, Kathleen George, Tim R. Cressey, Nahida Chakhtoura, Elizabeth Smith, David E. Shapiro, Mark Mirochnick, IMPAACT P1026s Protocol Team. Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women. Journal of Acquired Immune Deficiency Syndromes. 2016. 72: 289-96. PMID: 26918544
Year
Journal
Study
Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
Citation
Nikki Mulligan, Stein Schalkwijk, Brookie M Best, Angela Colbers, Jiajia Wang, Edmund V Capparelli, Jose Molto, Alice M Stek, Graham Taylor, Elizabeth Smith, Carmen Hidalgo Tenorio, Nahida Chakhtoura, Marjo Van Kasteren, Courtney V Fletcher, Mark Mirochnick, David Burger. Etravirine Pharmacokinetics in HIV-Infected Pregnant Women. Frontiers in Pharmacology. 2016. 7: 239. PMID: 27540363
Year
Journal
Study
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV
Citation
Nikki Mulligan, Brookie M Best, Jiajia Wang, Edmund V Capparelli, Alice Stek, Emily Barr, Shelley L Buschur, Edward P Acosta, Elizabeth Smith, Nahida Chakhtoura, Sandra Burchett, Mark Mirochnick, IMPAACT P1026s Protocol Team. Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV. AIDS. 2018. 32: 729-737. PMID: 2969162
Year
Journal
Study
Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial
Citation
Dorothy Sebikari, Mona Farhad, Terry Fenton, Maxensia Owor, Jeffrey S A Stringer, Min Qin, Nahida Chakhtoura, Benjamin H Chi, Friday Saidi, Neetal Nevrekar, Avy Violari, Tsungai Chipato, James McIntyre, Dhayendre Moodley, Taha E Taha, Gerhard Theron, Mary Glenn Fowler. Risk Factors for Adverse Birth Outcomes in the PROMISE 1077BF/1077FF Trial. Journal of Acquired Immune Deficiency Syndromes. 2019. 81: 521-532. PMID: 31295174
Year
Journal
Study
Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum
Citation
Ahizechukwu C Eke, Nahida Chakhtoura, Angela Kashuba, Brookie M Best, Craig Sykes, Jiajia Wang, Alice M Stek, Elizabeth Smith, Samantha Calabrese, Edmund V Capparelli, Mark Mirochnick, IMPAACT P1026s Protocol Team. Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and Postpartum. Journal of Acquired Immune Deficiency Syndromes. 2018. 78: 308-313. PMID: 29528944
Year
Journal
Study
Efavirenz pharmacokinetics during pregnancy and infant washout
Citation
Regis Kreitchmann, Stein Schalkwijk, Brookie Best, Jiajia Wang, Angela Colbers, Alice Stek, David Shapiro, Tim Cressey, Mark Mirochnick, David Burger. Efavirenz pharmacokinetics during pregnancy and infant washout. Antiviral Therapy. 2019. 24: 95-103. PMID: 30530925
Year
Journal
Study
Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study
Citation
Rolando M Viani, Theodore Ruel, Carmelita Alvero, Terry Fenton, Edward P Acosta, Rohan Hazra, Ellen Townley, Paul Palumbo, Ann M Buchanan, Cindy Vavro, Rajendra Singh, Bobbie Graham, Patricia Anthony, Kathleen George, Andrew Wiznia, P1093 Study Team. Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study. Journal of the Pediatric Infectious Diseases Society. 2020. 9: 159-165. PMID: 30951600